Covid-19 crisis: South Africa aims to vaccinate 1.1 mn by end of March

Addressing parliament, SA health minister also said authorities might have to inoculate more than their original target of 40 million people to reach herd immunity

Covid-19 crisis: South Africa aims to vaccinate 1.1 mn by end of March
The country, hit far harder by the pandemic than any other in Africa, started rolling out Johnson & Johnson's (J&J) vaccine last week in a research study targeting healthcare workers
Reuters
2 min read Last Updated : Feb 25 2021 | 8:44 PM IST
South Africa aims to vaccinate around 1.1 million people against COVID-19 by the end of March as it ramps up its immunisation programme, Health Minister Zweli Mkhize said on Thursday.
 
Addressing parliament, Mkhize also said authorities might have to inoculate more than their original target of 40 million people to reach herd immunity.
 
The country, hit far harder by the pandemic than any other in Africa, started rolling out Johnson & Johnson's (J&J) vaccine last week in a research study targeting healthcare workers. It hopes to receive doses of the Pfizer vaccine soon.
 
Mkhize said so far more than 32,000 health workers had been given the J&J shot.
 
Previously, South Africa said it had secured 20 million doses from Pfizer and 9 million from J&J.
 
But Mkhize said those numbers were just "opening negotiations" and final volumes were likely to be different.

"Once it is finalised we will announce new numbers very soon," he said.
 
Authorities had estimated that, to ensure population herd immunity, at least 40 million people needed to be vaccinated.
 
However, "as we go on with our discussions, it does appear we may have to do more than 40 million," Mkhize told parliament's upper house.
 
Mkhize, a trained medical doctor, said on Tuesday that government advisers had grouped COVID-19 vaccines into three categories and those considered for "immediate use" were the J&J, Pfizer and Moderna shots.
 
A health ministry presentation on Thursday said "full licensing" through local medicines regulator SAHPRA for J&J's vaccine could take "a couple of months".
 
South Africa has recorded around 1.5 million COVID-19 cases and 49,500 deaths to date, respectively over one-third and almost half of Africa's totals.
 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusSouth AfricaCoronavirus Vaccine

Next Story